Biologic Drugs May Be Cheaper, But Are They Safe?
Biologics are an exciting new world of medicine. But the EMA's new guidelines should put patient safety first by requiring biosimilars to be held to the same safety and standards as the original drug.
John Horton | Posted 05.25.2011